Navigation Links
Regulus to Present at Cowen and Company 33rd Annual Healthcare Conference
Date:2/26/2013

LA JOLLA, Calif., Feb. 26, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Garry E. Menzel , Ph.D., Chief Operating Officer and Executive Vice President, Finance, will present a company overview at the Cowen and Company 33rd Annual Healthcare Conference on Tuesday, March 5, 2013 at 8:40 am EST.  The conference is being held at the Boston Marriott Copley Place.

The presentation will be webcast at the time of the presentation and can be accessed on the Investor Relations page of the Company's website at www.regulusrx.com.  A replay of each webcast will be archived on the Company's website for two weeks following the presentation date.

About Regulus

Regulus Therapeutics Inc. (NASDAQ: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is leveraging a mature therapeutic platform based on technology that has been developed over 20 years. Regulus works with a broad network of academic collaborators and leverages the oligonucleotide drug discovery and development expertise of its founding companies, Alnylam Pharmaceuticals and Isis Pharmaceuticals. Regulus is advancing microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis, hepatitis C and metabolic diseases. Regulus has formed strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi and a research collaboration with Biogen Idec.

For more information, please visit http://www.regulusrx.com.

Forward-Looking Statements

Statements contained in this press release regarding matters tha
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
2. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
3. Regulus to Present at Two Upcoming Investor Conferences
4. Regulus Appoints Mark G. Foletta to its Board of Directors
5. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
6. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
7. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
8. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
9. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
10. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
11. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group has ... their competitive landscape map for the Chronic Kidney ... 90 international companies with drugs and devices currently ... and its sequelae. (Logo:  ... , hypertension - renal denervation , ...
(Date:5/17/2013)... 17, 2013  Boehringer Ingelheim will contribute to ... the American Thoracic Society International Conference (ATS 2013) ... 17 – 22. Data will highlight ... treatment of chronic obstructive pulmonary disease (COPD) [Spiriva® ... investigational compounds for asthma, idiopathic pulmonary fibrosis (IPF) ...
(Date:5/17/2013)... 2013 Sinovac Biotech Ltd. (Nasdaq: SVA ... , today announced that it will release its unaudited ... before market on Tuesday, May 28, 2013.  The Company will ... 8:00 a.m. EDT (May 28, 2013 at 8:00 p.m. China ... an update on recent corporate developments. To access ...
Breaking Medicine Technology:TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3
... 22, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: ... announced today it has filed its Annual Report on Form ... year ended December 31, 2010 on April 22, 2011.  The ... www.sec.gov . The Company will provide a hard ...
... One hundred and eighty miles — Houston to Austin, ... MS 150 overcame on April 16 and 17 in a ... sponsored by The SCOOTER Store , the nation,s leading ... ride and raised nearly $20,000 toward the cause. ...
Cached Medicine Technology:Sinovac Files Annual Report on Form 20-F 2The SCOOTER Store Supports Fight Against Multiple Sclerosis 2
(Date:5/19/2013)... new measure of the heterogeneity the variety of genetic ... treatment outcomes of patients with the most common type of ... of the journal Cancer , investigators at Massachusetts General ... their measure was a better predictor of survival than most ... squamous cell carcinoma of the head and neck. ...
(Date:5/19/2013)... York, NY (PRWEB) May 19, 2013 ... for his two concerts in Vegas in October will ... Additionaly, during the spring and summer months of 2013, ... country. , Whenever people hear “It’s Five O’clock ... hear the voice of Jimmy Buffett inside their heads. Fortunately, ...
(Date:5/19/2013)... A leading symptom of peripheral neuropathy, the ... end through natural ways, such as Neuracel’s Ultimate Support ... number of different underlying problems, the most commonly diagnosed ... is characterized by damage to the peripheral nerves in ... larger system, the peripheral nervous system. The peripheral nervous ...
(Date:5/19/2013)... , , SATURDAY, May 18 (HealthDay News) -- Vitamin ... overcome the fatigue and decreased muscle strength associated ... research. Extra vitamin D "was associated with ... quality of life and the ability to perform ... research dietitian and doctoral candidate at Trinity College ...
(Date:5/19/2013)... Omaha, Nebraska is a city of diversity, ... one of the lowest unemployment rates in the country. Forbes ... Places for Business and Careers and it consistently scores high ... centrally located in the nation and is a strong business ... producers of Editions TV are pleased to announce ...
Breaking Medicine News(10 mins):Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 2Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 3Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 2Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 3Health News:Peripheral Neuropathy Naturally Treatable Through Neuracel's Ultimate Neuropathy Support System 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2
... in breast cancer a master control switch with the ... a cancer-causing gene (or oncogene) named Wnt1. This executive molecule ... on the cover of the August 15 issue of ... of a Wnt oncogene," explains lead author Rakesh Kumar, Ph.D., ...
... By Jenifer Goodwin HealthDay Reporter , ... mistakes, admitting the error, saying "I,m sorry" and offering ... lawsuits, new research shows. In 2001, University ... workers to report medical mistakes. The program included a ...
... The Community Living Assistance Services and Supports (CLASS) Act ... Affordable Care Act has the potential to transform long-term ... an insurance-based system, according to the latest issue of ... ). With funding from The SCAN Foundation , ...
... release is available in French . , Montreal, ... parental monitoring are more likely to befriend deviant peers and ... study published in the journal Addictive Behaviors . Yet ... Sainte-Justine University Hospital Research Center found that bad boys can ...
... Alberta research fellow Amy Speed-Andrews has examined how a specialized ... cancer, and who have completed treatment, makes a difference in ... were asked to fill out a questionnaire about their physical ... of Iyengar yoga and again at the end. After analyzing ...
... Washington engineers are developing the first device able to ... tool is just completing its initial field test by ... hard-of-hearing students. "This is the first study of how ... phones," said project leader Eve Riskin, a UW professor ...
Cached Medicine News:Health News:Researchers identify breast cancer culprits 2Health News:When Doctors Admit Mistakes, Fewer Malpractice Suits Result, Study Says 2Health News:When Doctors Admit Mistakes, Fewer Malpractice Suits Result, Study Says 3Health News:CLASS Act analysis reveals America's long-term care future 2Health News:Heavy drug-use among bad boys curbed by parental monitoring and peers 2Health News:Deaf, hard-of-hearing students perform first test of sign language by cell phone 2Health News:Deaf, hard-of-hearing students perform first test of sign language by cell phone 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: